Table 4

Percentage (95% CI) of respondents rating each type of medication as "helpful" for the person described in the vignette

Medication

Country

Depression Vignette

Depression/Suicidal Vignette

Early Schizophrenia Vignette

Chronic Schizophrenia Vignette


Vitamins, minerals

Australia

50.2 (45.4–55.1)

43.7 (39.2–48.3)

31.3 (27.4–35.5)

33.2 (28.9–37.8)

Japan

20.2 (16.7–23.7)

16.4 (13.1–19.7)

10.6 (7.9–13.3)

12.4 (9.5–15.3)

Pain relievers

Australia

14.8 (11.7–18.5)

12.3 (9.6–15.7)

7.3 (5.3–9.9)

10.2 (7.7–13.4)

Japan

4.4 (2.6–6.2)

3.6 (2.0–5.2)

4.2 (2.4–6.0)

4.6 (2.8–6.4)

Antidepressants

Australia

46.7 (42.4–51.1)

52.5 (48.1–56.7)

49.9 (45.7–54.2)

42.6 (37.9–47.5)

Japan

34.8 (30.6–39.0)

36.0 (31.8–40.2)

38.6 (34.3–42.9)

39.8 (35.5–44.1)

Antibiotics

Australia

10.4 (7.9–13.7)

7.9 (5.7–10.8)

4.0 (2.5–6.2)

6.4 (4.5–9.1)

Japan

6.2 (4.1–8.3)

6.0 (3.9–8.1)

4.8 (2.9–6.7)

8.4 (6.0–10.8)

Sleeping pills

Australia

23.9 (20.1–28.1)

21.9 (18.6–25.6)

18.1 (14.7–22.1)

11.6 (8.8–15.1)

Japan

31.6 (27.5–35.7)

26.2 (22.3–30.1)

21.4 (17.8–25.0)

24.8 (21.0–28.6)

Antipsychotics

Australia

11.2 (8.4–14.8)

16.5 (13.3–20.3)

33.1 (29.0–37.5)

38.2 (34.0–42.6)

Japan

22.6 (18.9–26.3)

21.8 (18.2–25.4)

30.2 (26.2–34.2)

41.2 (36.9–45.5)

Tranquillizers

Australia

13.8 (11.0–17.1)

13.8 (11.0–17.1)

17.2 (14.1–20.8)

15.3 (12.6–18.4)

Japan

38.4 (34.1–42.7)

37.0 (32.8–41.2)

38.4 (34.1–42.7)

45.4 (41.0–49.8)


Jorm et al. BMC Medicine 2005 3:12   doi:10.1186/1741-7015-3-12

Open Data